Top Gainers: Accelrys, Inc. (NASDAQ:ACCL), Infinera Corp. (NASDAQ:INFN), LiqTech International Inc (NYSEMKT:LIQT), Geron Corporation (NASDAQ:GERN)

Accelrys Inc (NASDAQ:ACCL) announced that Dassault Systems SA agreed to buy Accelrys Inc. for $750 million to expand its offering in molecular chemistry and life sciences. Accelrys, Inc. (NASDAQ:ACCL) stock opened at $12.50 in last session, and closed at $12.57, while the day range of stock is $12.48 – $12.58. The stock showed a positive weekly performance of 20.06%.

Infinera Corp. (NASDAQ:INFN) issued its quarterly earnings data on Wednesday. The company reported $0.00 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.02, StockRatingsNetwork reports. Infinera Corp. (NASDAQ:INFN) stock opened at $8.42, in last session and closed at $9.11, by gaining 29.04%. The 52 week range of the stock is $6.06 – $12.16. Company’s market capitalization is $1.09 billion.

LiqTech International Inc (NYSEMKT:LIQT) is pleased to announce that after extensive and successful testing LiqTech has received a production order for flat sheet silicon carbide membranes from the Middle East. LiqTech International Inc (NYSEMKT:LIQT) stock advanced 28.44% and finished the last session at $2.71. The EPS of the stock remained -0.21. Company’s market capitalization is $67.24 million.

Shares of Geron Corporation (NASDAQ:GERN) fell over 15% on Monday and, at first glance, the problem appeared to be the company’s 8-K. In that filing, the company disclosing that 25% of patients enrolled in an early stage trial for Geron’s experimental treatment for myelofibrosis, called imetelstat, dropped out. Geron Corporation (NASDAQ:GERN) stock opened the session at $4.38, and closed the session at $5.35. The 52 week range of the stock remained $0.98 – $7.79 and the day range was $4.29 – $5.54.